Rhythm Pharmaceuticals, Inc. Made Big Gain

Tue, Jul 12, 2022 at 08:30 PM
Rhythm Pharmaceuticals, Inc. Made Big Gain

Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ) rocketted at $6.67, a gain of 42.2%. On Tue, Jul 12, 2022, RYTM:NASDAQ touched a New 2-Week High of $6.67. The stock appeared on our News Catalysts scanner on Tue, Jul 12, 2022 at 07:35 AM in the 'BIOTECH' category. From Tue, Jun 28, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days

About Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ)

Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.